ExactVu Micro-US delivers 300 percent higher resolution than standard ultrasound

Using ExactVu Micro-US, doctors benefit from a 300 percent improvement in resolution over conventional ultrasound for more precise diagnosis. Doctors use live Micro-US images for better detection and evaluation of the aggressiveness level of the cancer.


The urologist's ability to view the patient's anatomy, detect suspicious areas, differentiate between benign and cancerous tissue, and target specific areas for biopsy makes Micro-US technology the new standard of care.

All the quality of an MRI at lower cost

Also, with Micro-US, urologists get the same high quality visualization as an MRI to guide the biopsies. So rather than sending the patient for an MRI, which is an additional imaging procedure that needs to be billed independently – and not always covered by insurance – the Micro-US-guided biopsy is performed in the same setting as the standard ultrasound-guided biopsy, and is always covered by insurance.

"Besides being as good as an MRI scan, Micro-US can be done in the urologist's office, at lower cost," Dr. Andriole said. "Also, for some patients who are claustrophobic or have a pacemaker, MRI may be prohibitive. With Micro-US we can advance the biopsy needle right up to the edge of the suspicious area, press the button and the biopsy core will go right through the most worrisome part of the prostate. The accuracy of finding a cancer within the prostate, if there is one, is much higher."

For more information about ExactVu Micro-US visit https://us.edap-tms.com/home/us.


About EDAP TMS
A recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally-invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® (currently pending FDA clearance) in 2013 as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.


Back to HCB News

Business Affairs Homepage